In a previous study, we demonstrated that EB-WE administration improved ischemic brain injury induced by carotid artery occlusion in rats through the upregulation of NRF-2 (nuclear factor erythroid 2-related factor 2) and HO-1 (heme oxygenase-1) expression [15]. The gene discussed is NFE2L2; the disease is brain injury.